Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 6, 2005JNCI Journal of the National Cancer InstituteOpen Access

Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17

View Full Paper
Ask AI
Bookmark
Share

Authors

PGPaul E. GossHarvard UniversityJIJames N. IngleUniversity of VermontSMSilvana MartinoUniversity of Vermont

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Goss et al. (2005) studied this question.

synapsesocial.com/papers/6a170feff3be5e880d6be693https://doi.org/10.1093/jnci/dji250
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Survival Analysis Techniques for Censored and Truncated Data1998 · 3,576 citations
  2. 2Clinical pharmacology of tamoxifen in patients with breast cancer: Correlation with clinical data1981 · 87 citations
  3. 3Postchemotherapy Adjuvant Tamoxifen Therapy Beyond Five Years in Patients With Lymph Node-Positive Breast Cancer1996 · 202 citations
  4. 4Estrogen and the Risk of Breast Cancer2001 · 1,101 citations